H Wang, H Guo, J Yang, Y Liu, X Liu, Q Zhang… - … Hematology & Oncology, 2022 - Springer
Targeting B-cell receptor signalling using Bruton tyrosine kinase (BTK) inhibitors (BTKis) has
become a highly successful treatment modality for B-cell malignancies, especially for …